personalized, responsive service and to improve the site, we remember and store information about how you use
The Translational Scientist
This month, we’re looking at biomarkers in clinical trials – should we apply a “No Biomarker, No Trial” rule to speed up oncology drug development? It’s a mission not quite so impossible in our feature, highlighting new research in pancreatic cancer. We go in search of HIV’s Achilles’ heel with Profectus, whose new HIV vaccine is just entering clinical trials. Plus, our “In Perspective” section reflects on the importance of asking the right question. Finally, we’re “Sitting Down With” Julian Solway, who started out in electrical engineering before finding his calling as a doctor and translational scientist.